DNTH
#1276
Dianthus Therapeutics, Inc. - Common Stock
101.2 8 USD
+0.03%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
+2.68%
Monthly Change
+22.75%
6 month change
+128.52%
Year Change
+428.33%
Previous Close
98.6 4
Open
101.3 6
Low
101.2 8
High
101.3 6
Volume
172
Financials
- Market Capitalization 5.54 B
- Employee 92
- Founded 2019
- CEO N/A
- Website www.dianthustx.com
- Headquarter Delaware, United States
- FIGI BBG00FB2NPZ0
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-9.81
Price to sales ratio
781.65
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 1221 |  LGND Ligand Pharmaceuticals Incorporated - Common Stock | 300.97 USD | -2.68% | -6.50% | +17.98% | +60.84% | 6.03 B USD | ||
| 1250 |  BLTE Belite Bio Inc - American Depositary Shares | 146.68 USD | -0.24% | -5.67% | +1.17% | +132.42% | 5.77 B USD | ||
| 1286 |  CELC Celcuity Inc. - Common Stock | 111.05 USD | +6.99% | -2.59% | +25.42% | +700.65% | 5.42 B USD | ||
| 1299 |  TVTX Travere Therapeutics, Inc. - Common Stock | 57.06 USD | +1.37% | -0.77% | +5.90% | +98.33% | 5.31 B USD |
Frequently asked questions about Dianthus Therapeutics, Inc. - Common Stock
What is the Dianthus Therapeutics, Inc. - Common Stock stock price today?
The current price of Dianthus Therapeutics, Inc. - Common Stock (DNTH) is 101.28. Over the past 24 hours, the stock has changed by +2.68%. Follow the DNTH chart for real-time price dynamics.
What is the stock ticker of Dianthus Therapeutics, Inc. - Common Stock?
Dianthus Therapeutics, Inc. - Common Stock trades under the ticker DNTH. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Dianthus Therapeutics, Inc. - Common Stock stock going up?
DNTH has changed by +5.73% over the last week, +22.75% over the last month, and +428.33% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Dianthus Therapeutics, Inc. - Common Stock net income for the last quarter?
Dianthus Therapeutics, Inc. - Common Stock reported net income of -40.83 M for the last quarter. The previous quarter showed -64.43 M, which means net income changed by +36.62%.
How many employees does Dianthus Therapeutics, Inc. - Common Stock have?
As of the latest available data, Dianthus Therapeutics, Inc. - Common Stock has 92 employees. Workforce size can provide additional context about the company's scale and operations.
What is Dianthus Therapeutics, Inc. - Common Stock EBITDA?
Dianthus Therapeutics, Inc. - Common Stock EBITDA is -41.93 M, and its EBITDA margin is -670.91%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Dianthus Therapeutics, Inc. - Common Stock stock?
You can buy Dianthus Therapeutics, Inc. - Common Stock (DNTH) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Dianthus Therapeutics, Inc. - Common Stock stock?
Investing in Dianthus Therapeutics, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the DNTH chart and related analysis on metatrader.com as part of your research.